You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer
- 2. Cardiovascular adverse effects of immunotherapy in cancer: insights and implications
- 3. Research progress on FOXM1 in ovarian cancer diagnosis and therapeutics
- 4. Fusobacterium nucleatum promotes metastasis of breast cancer via the miR-21-3p/FOXO3 axis
- 5. A pan-cancer analysis of the prognostic and immunological roles of zinc finger protein 514 in human tumors
- 6. Singlera Genomics and Partners publish results from GUIDE prospective cohort study demonstrating blood-based early detection of gastrointestinal cancers using DNA methylation-based GutSeer assay
- 7. Amplia Therapeutics achieves second complete response with narmafotinib in pancreatic cancer trial
- 8. Development and validation of hybrid machine learning approach for predicting survival in patients with cervical cancer: a SEER-based population study
- 9. Human annexin A5 promotes glioma progression by targeting the MAPK/CD44 pathway
- 10. PreciseDx Secures $11M in New Funding
Last updated at 3:46 GMT
Hot News Makers
Health/Pharma Companies
-
1474283.15
-
17316.98
-
7731.70
-
5713.59
-
5300.49
-
5198.80
-
5071.79
-
4684.15
-
4665.12
-
3943.64
Drugs, Treatments, Trials
-
7825.67
-
5776.11
-
4863.37
-
3783.41
-
2681.77
-
1509.88
-
1431.15
-
1017.61
-
982.52
-
974.80
Last updated at 3:10 GMT
